Detection kit and application thereof in assessing schizophrenia genetic risk
A detection kit and technology for schizophrenia, applied in the direction of microbial determination/examination, biochemical equipment and methods, etc., can solve the problems of delayed diagnosis and treatment, difficult treatment, lack of tools to provide objective support for clinical diagnosis, etc. The effect of reducing burden, wide product coverage, and ensuring accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055] Example 1: A method for assessing the genetic risk of schizophrenia using the detection kit
[0056] A method for evaluating the genetic risk of schizophrenia using the detection kit, which specifically includes the following steps:
[0057] (1) Take a human peripheral anticoagulant blood sample, first use a commercial nucleic acid extraction kit to extract human genomic DNA samples, and test the extracted DNA, requiring A260 / A280 between 1.6-2.0, concentration ≥ 20ng / μL . The concentration of DNA and the ratio of A260 / A280 in the present embodiment are as follows:
[0058] A260 / A280
C (ng / μL)
1.70
87
[0059] (2) Take 20 μL of capture reaction solution, add 1.2 μL of DNA extracted in step (1) and 3.8 μL of purified water;
[0060] Wherein the composition of capture reaction solution is as follows:
[0061] components
Volume (μL)
5×PCR buffer
5
dNTP Mix(10mM)
0.25
DNA Polymerase (10U / μL)
0.6
...
Embodiment 2
[0084] (1) using the DNA sample extracted by (1) step in Example 1;
[0085] (2) Take 20 μL of capture reaction solution, add 1.2 μL of DNA extracted in (1) and 3.8 μL of purified water
[0086]
[0087]
[0088] All the other conditions are the same as in Step 2 of Example 1.
[0089] After the PCR amplification was completed, the PCR product was detected by electrophoresis on a 2% agarose gel, and the loading volume of the PCR product was 5 μL. (See figure 2 )
[0090] (3) Product purification
[0091] The purification steps are the same as Step 3 of Example 1. Use Qseq100 to detect the fragment size after product purification, where image 3 is the fragment size after purification of the product obtained according to condition 1; Figure 4 is the fragment size after purification of the product obtained according to condition 2; Figure 5 is the fragment size after purification of the product obtained according to condition 3; Image 6 is the fragment size aft...
Embodiment 3
[0093] Take a clinical anticoagulant blood sample, operate according to the steps in Example 1, and sequence the samples that pass the quality inspection on a high-throughput sequencer. The sequencing depth of each site is as follows Figure 7 shown. It can be seen from the figure that the samples processed by this kit were sequenced on a high-throughput sequencer, and all 123 sites were successfully sequenced, and the uniformity of the sequencing depth of each site was good.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


